Ring Therapeutics
Garry Nolan is an accomplished professional with extensive experience in facilities and operations management, currently serving as the Executive Director of Facilities and Operations at Ring Therapeutics since February 2024. Prior to this, Garry held the role of Executive Director of Facilities at Seres Therapeutics from November 2020 to January 2024, and Senior Director of Operations at Fulcrum Therapeutics between March 2018 and June 2020, where responsibilities included program management and oversight of facility infrastructure. Earlier roles include Director of Facilities at Seres Therapeutics, Director of Operations at Verastem, and Management positions at Dana-Farber Cancer Institute, PPD, Inc, and CombinatoRx, Inc. Garry's educational background includes studies at Liverpool John Moores University.
This person is not in any teams
Ring Therapeutics
Ring Therapeutics' Anellogy™ platform aims to usher in a new era of gene therapy using the human commensal virome.